Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    Neurodegeneration with Brain Iron Accumulation
Show Display Options
Rank Status Study
1 Recruiting Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-associated Neurodegeneration (PKAN)
Intervention:
2 Enrolling by invitation Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: Deferiprone oral solution;   Drug: Deferiprone
3 Active, not recruiting Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)
Conditions: Neurodegenerative Disease;   Iron Overload
Intervention: Drug: Deferiprone
4 Recruiting A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: Deferiprone oral solution;   Drug: Placebo oral solution
5 Completed Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: deferiprone;   Drug: placebo

Indicates status has not been verified in more than two years